How many stocks are there of Insulet?
The current number of stocks of Insulet is 73.89 M undefined.
Insulet Stocks 2025
Insulet Stocks
73.89 M
Ticker
PODD
ISIN
US45784P1012
WKN
A0MQX8
In 2025, Insulet had 73.89 M outstanding stocks, a 0% change from the 73.89 M stocks in the previous year.
The Insulet Stocks history
| YEAR | NUMBER OF STOCKS (M USD) |
|---|---|
| 2030e | 73.89 |
| 2029e | 73.89 |
| 2028e | 73.89 |
| 2027e | 73.89 |
| 2026e | 73.89 |
| 2025e | 73.89 |
| 2024 | 73.89 |
| 2023 | 73.63 |
| 2022 | 69.9 |
| 2021 | 68.6 |
| 2020 | 65.9 |
| 2019 | 62.3 |
| 2018 | 61 |
| 2017 | 58 |
| 2016 | 57.3 |
| 2015 | 56.8 |
| 2014 | 55.6 |
| 2013 | 54 |
| 2012 | 47.9 |
| 2011 | 46.7 |
| 2010 | 39.6 |
| 2009 | 29.7 |
| 2008 | 27.6 |
| 2007 | 16.7 |
| 2006 | 25.6 |
| 2005 | 25.6 |
Insulet shares outstanding
The number of shares was Insulet in 2024 — This indicates how many shares 73.89 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Loading chart...
Number of stocks
Details
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Insulet earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Insulet's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Insulet’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Insulet's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
Insulet Aktienanalyse
What does Insulet do?
Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Insulet's Shares Outstanding
Insulet's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Insulet’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Insulet’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Insulet’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Insulet stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Insulet are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Insulet evolved in recent years?
The number of shares of Insulet has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Insulet as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Insulet?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Insulet pay?
Over the past 12 months, Insulet paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Insulet is expected to pay a dividend of 0 USD.
What is the dividend yield of Insulet?
The current dividend yield of Insulet is .
When does Insulet pay dividends?
Insulet pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Insulet?
Insulet paid dividends every year for the past 0 years.
What is the dividend of Insulet?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Insulet located?
Insulet is assigned to the 'Health' sector.
Wann musste ich die Aktien von Insulet kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Insulet from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did Insulet pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of Insulet in the year 2024?
In the year 2024, Insulet distributed 0 USD as dividends.
In which currency does Insulet pay out the dividend?
The dividends of Insulet are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Insulet stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Insulet
Our stock analysis for Insulet Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Insulet Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
